Sisi, Monia http://orcid.org/0000-0002-0395-6038
Fusaroli, Michele
De Giglio, Andrea
Facchinetti, Francesco
Ardizzoni, Andrea
Raschi, Emanuel
Gelsomino, Francesco
Article History
Accepted: 16 December 2021
First Online: 13 January 2022
Declarations
:
: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Authors from the University of Bologna (Emanuel Raschi, Andrea Ardizzoni) are supported by Institutional Research Funds (Ricerca Fondamentale Orientata).
: Dr. F. Facchinetti reports personal fees from BMS and ROCHE, outside the submitted work. Prof. A. Ardizzoni reports grants and personal fees from BMS, personal fees from Eli-Lilly, Pfizer, MSD and Boehringer; grants from Celgene, outside the submitted work. Dr. F. Gelsomino reports personal fees from AstraZeneca and Eli-Lilly, outside the submitted work. Prof E. Raschi reports personal fees from Novartis, outside the submitted work. Dr. M. Sisi, Dr. M. Fusaroli, Dr. A. De Giglio declare that they have no conflicts of interest that might be relevant to the contents of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: The datasets generated and/or analyzed during the current study are available in the Food and Drug Administration Adverse Events Reporting System (FAERS) repository, [].
: <i>Conceptualization:</i> Emanuel Raschi, Francesco Gelsomino. <i>Data curation:</i> Monia Sisi, Michele Fusaroli, Andrea De Giglio, Emanuel Raschi, Francesco Gelsomino. <i>Investigation:</i> Monia Sisi, Michele Fusaroli, Andrea De Giglio, Emanuel Raschi, Francesco Gelsomino. <i>Visualization:</i> Monia Sisi, Michele Fusaroli, Andrea De Giglio, Francesco Facchinetti, Andrea Ardizzoni, Emanuel Raschi, Francesco Gelsomino. <i>Writing-original draft preparation:</i> Monia Sisi. <i>Writing</i>-<i>reviewing and editing:</i> Michele Fusaroli, Andrea De Giglio, Francesco Facchinetti, Andrea Ardizzoni, Emanuel Raschi, Francesco Gelsomino. <i>Supervision:</i> Andrea Ardizzoni, Emanuel Raschi, Francesco Gelsomino. <i>Methodology:</i> Michele Fusaroli, Emanuel Raschi. <i>Software:</i> Michele Fusaroli, Emanuel Raschi. All authors read and approved the final version of the paper.